TP53 and ovarian carcinoma: In the present study, we found a significant correlation between the expression of p21/p53/RUNX3 and EZH2 in ovarian cancer: downregulation or inhibition of EZH2 could increase the expression of p21, p53, and RUNX3, and upregulation of EZH2 caused decreased expression.